- Projects & figures
- News & Events
- Managing your project
- About ERC
More than 3.5 million new people are diagnosed with heart failure every year in Europe, with a long-term prognosis of 50% mortality within four years. There is urgent need for more innovative, regenerative therapies with the potential to change the course of the condition.
Living creatures relate to their surroundings in all kinds of ways. One of these is by eating from them and excreting into them. But what is eating? Incorporating other creatures or absorbing nutrients? A need of individual bodies or a pleasure that table companions share? The ERC project EATINGBODIES has explored such questions by studying various forms of eating.
The starting point of this research project is the disproportionality between the alleged “crime” of being an undocumented migrant and the sanction of deportation. But what determines the ways in which deportation is being implemented on the ground? What are the factors that prevent or expedite implementation?
How close are we to developing a successful and comprehensive vaccine for cancer? ERC grantee Prof. Yvette van Kooyk thinks that a combination of glycobiology and immunology will lead us closer than ever before. Thanks to her ground-breaking multidisciplinary team and her new approach based on sugar receptors, she has developed a nanovaccine that promises to represent the future for cancer treatment.
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy-associated malaria, to save the lives of women and their babies in areas affected by the disease. Now, Dr Salanti’s research has shifted to battling against another deadly disease: cancer. This comes after an unexpected discovery yielded ground-breaking results for the diagnosis and treatment of this illness. This is the kind of curiosity-driven research that can lead to ground-breaking serendipitous outcomes.